Clinical study on of combination therapy with a DPP-4 inhibitor and a mitiglinide/voglibose fixed-dose combination (the combination) on glycemic/metabolic responses after meals in patients with type 2 diabetic mellitus (T2DM) - Clinical study on combination therapy with a DPP-4 inhibitor and the combination in T2DM patients
开始日期2013-11-18
申办/合作机构-
JPRN-UMIN000011167
/ CompletedN/AIIT
Efficacy and safety of switching from thrice daily glinide or alpha-GI to twice daily mitiglinide/voglibose combined drug in type 2 diabetes. - Efficacy and safety of switching from thrice daily glinide or alpha-GI to twice daily mitiglinide/voglibose combined drug in type 2 diabetes.
开始日期2013-07-23
申办/合作机构-
JPRN-UMIN000008332
/ CompletedN/AIIT
Evaluation of effect of Glubes combination tablet on the HbA1c levels and vascular endothelial function - EGEF trial